Religare Broking reiterated its ‘Buy’ rating on ICICI Life Insurance, with a target price of ₹650, implying a 42.6% upside. The brokerage cited leadership continuity, distribution strategy and operating efficiency as key growth drivers, while flagging near-term softness in some product segments.